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ABSTRACT
A one-step process for the production of nanoparticles presenting advanced magnetic 
properties can be achieved using vapor condensation. In this paper, we report on the 
fabrication of Fe particles covered by a uniform MgO epitaxial shell. MgO has a lower 
surface energy than Fe, which results in a core-shell crystal formation. The particles are 
proven to be useful as as contrast agents for magnetic resonance diagnosis and heating 
mediators for cancer therapy through hyperthermia. They also have potential to be used in 
drug delivery and magnetic-activated cell sorting.
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I. INTRODUCTION
Over the past decades, an increasing number of materials in the nanometer scale have been 
used in biomedical applications.1 In particular, the field of nanomagnetism holds great promise for 
diagnosis and targeted treatment of human diseases. For instance, combined fluorescence and 
magnetic resonance imaging (MRI) has become an indispensable tool in cancer research.2,3 However, 
expectations on magnetic approaches have not been fully accomplished, since most of the magnetic 
nanoparticles (NPs) intended to-date have the disadvantage of been based on superparamagnetic 
oxides which do not provide a sufficiently large magnetic stray field for high-resolution detection 
schemes, cell sorting, and magnetically guided drug targeting. 4, 5, 6,7
In addition to addressing the drawbacks of toxicity level, size reproducibility and weak 
magnetic properties, the cost and ease of processing should also be considered as key issues for 
commercialization. In this context, chemical synthesis is a preferred way to elaborate large 
quantities of well-controlled NPs.8 Nonetheless, the use of precursors in the presence of a large 
amount of surfactants leads to impurities in the final product that may hampers in-vivo applications. 
Besides, using the ultrasmall particles achievable within the aforementioned syntheses is not always 
better when it comes to medicine. Only recently, researchers have demonstrated that spherical 
particles with a diameter ~ 50 nm are taken up by mammalian cells at a faster rate and higher 
concentration levels compared to other sizes and shapes. This optimal radius means that for the 
smaller particles to go in, they must be clustered together,9 as result of energy penalties arising from 
the curvature and cell membrane tension.10,11 Therefore different coatings on the particles, including 
inorganic shells or polymers, may lead to different cell uptake and nanocitoxicity,12 and influence 
many vital interactions within the body, including circulation and targeting.13,14,15 While a huge 
3number of methods have been developed for the scalable synthesis and preparation of inorganic 
metal and semiconductor nanoparticles, only a few specialized techniques were reported for the 
preparation of core-shell nanoparticles.16
These magnetism-engineered nanoprobes, when conjugated with antibodies, showed enhanced 
MRI sensitivity for the detection of cancer markers compared with probes currently available.17 As 
well, magnetic particles have been intensively studied as a promising support for tumour therapy
schemes, especially when dealing with cancer spreading through the lymph system. Several 
suggestions for optimizing the use of magnetic NPs in the thermal treatment of cancer tumour are 
known from literature. For instance, biomimetic material such as bacterial magnetosomes with a 
mean core diameter of 30 nm was recently proposed to overcome the drastically decrease in the 
heating power after immobilisation of particles when penetrating into the tissue.18 In addition, 
superior heating rates are expected if using magnetic materials with higher magnetization and 
hysteresis losses.
In this work we present an alternative way for synthesizing high quality metallic, soft 
ferromagnetic Fe nanoparticles with an outer protective MgO sheath, by using scalable one-step 
vapour-phase condensation. This technique allows the preparation of large volumes of concentrated 
nanoparticle dispersions presenting several important advantages over previously described 
solutions since it achieves a narrow particle size distribution without purification steps, thus 
reducing processing times. This novel, mechanically stable, biocompatible nanomaterial is shown to 
be suitable for hyperthermia and magnetic imaging, among other potential biomedical applications.
Shortly, in-vivo administration of pristine particles, not chemically modified or functionalized, 
shown that NPs were apparently cleared from blood stream quickly and distributed throughout most 
organs within 24 h. The primary accumulation in liver, kidneys and spleen showed a gradual 
decrease within the 3 weeks monitoring period, for which urinary, and eventually hepatobiliary 
4excretion into the intestinal tract, are considered as possible clearance pathways.19,20 It should be 
noted that Mg2+ ions exhibit a biological activity for bone regeneration and it is ubiquitous and 
essential to all living organism.21 Thus, magnesia shells provide non-toxic hydroxyl surface groups 
that would allow for surface functionalization by covalent linkages of drugs and biomolecules.22
II. METHODS
II.A.1. Synthesis: Precursors were prepared by mixing Fe (purity > 99.5% from BASF) and MgO (Alfa Aesar, 
99.998%) powders in the desired proportions. In view of the reactivity of Fe towards oxidation, it was felt to be 
particularly desirable to ensure the absence of iron oxides by using minute excess Mg (Aldrich, 99.9%) that provides 
reducing conditions.23 Targets obtained from cold-pressed precursors were vaporized inside a vacuum chamber. During 
synthesis, the pressure in the chamber was increased by introducing a stream of Ar inert gas. Different sources for 
evaporation were used. Shortly, when using an environmentally friendly process, solar radiation was channelled to an 
indoor laboratory via plane mirrors and concentrated onto the target using a parabolic mirror 2 m in diameter, as 
described in Ref. 24. The delivered solar power, measured using a calorimeter is around 1500 W when the incident sun 
flow is around 1 kW.m-2. When the energy source was kept and the pressure was reduced, nanoparticles nucleation and 
growth could be gradually adjusted and size diminished (from about 250 to 20 nm),25 as a result of the decrease in the 
mean free path of the vaporized atoms.26 Joule heating evaporation was also routinely employed with the same results. 
Nanomaterial was collected with rates up to 100 mg of powder per hour. 
II.A.2. Structure: The detailed structural and morphological characterization of our samples was carried out by 
means of scanning electron microscopy (SEM), X-ray diffraction (XRD) and high resolution transmission electron 
microscopy (HRTEM). The precise determination of the crystal phase was performed by means of the fast Fourier 
transform (FFT) method in each individual nanoparticle. Samples for observation were prepared by drop-casting a dilute 
ethanol solution of the particles onto carbon-coated copper grids and quickly evaporating the solvent. In order to obtain 
the HRTEM results we used a field emission gun microscope, JEOL 2010F, which works at 200 kV and has a point-to-
point resolution of 0.19 nm. Electron energy loss spectra (EELS) were obtained with an energy resolution of 1.2 eV. 
Energy Dispersive X-ray Analysis (EDX) was used to estimate the powder composition. The thermal stability and 
hydrogen uptake of the nanoparticles were measured in a thermobalance (TGA) at heating rates of 5 ºC.min-1.
5II.B.1. Magnetic properties: Mössbauer spectra were recorded by using a standard 512 channel spectrometer in 
transmission geometry with a 57Co in Rh matrix source. For low temperature measurements a He flow cryostat was used. 
Velocity calibration was done by using a thin α-Fe foil. Field and temperature dependent magnetic measurements were 
performed with a superconducting quantum interferometer device (SQUID) magnetometer in a range of –50 to 50 kOe 
and 10 to 350 K. By determining the total Fe amount in the SQUID sample using EDX analysis, we found that the 
saturation magnetization of our crystals was 210 ± 8 e.m.u. per metal gram at 300 K. Magnetic measurements and TEM 
analysis were repeated on some of the samples in order to examine any aging effects, without any degradation over a 
monitoring period of eighteen months exposure in high humidity-mild temperature Barcelona’s ambience conditions.
II.B.2. Hyperthermia studies: Heating experiments for comparing the heating capability of particles were 
performed in a simple arrangement using a water cooled induction coil of 23 mm diameter consisting of three turns. The 
ac field is generated by means of a commercial generator with a power of 4.5 kW. Particles to be investigated were 
homogeneously dispersed in a relatively large volume of water-based solution which was kept in a thermally isolated 
glass container inside the ac field coil. We used the grinding technique to produce NPs suspensions on water in the 
presence of soybean lecithin, allowing an exceptional green process for the production and stabilization of nanoparticles. 
The dissipated power due to the applied magnetic ac field was determined by measuring the initial slope of the 
temperature rise by means of a fiber optic temperature probe. As a control, the temperature rise of the water without 
nanoparticles present was also measured and subtracted from the temperature rise measured for the nanoparticles. It is 
widely believed that the heating effect is a result of absorbing energy from the alternating magnetic field and 
transforming it into heat by means of the hysteresis loss during reversal of magnetization. For that reason, and for the 
sake of comparison, the loss power was also determined from SQUID measured hysteresis losses assuming linear 
frequency dependence. A descendent loss power was detected while increasing concentration, which may be a signature 
of dipolar interactions influencing the NP intrinsic magnetic properties.27
II.C.1. In vitro Toxicity: Studies of biocompatibility were performed in the 3T3 cell line (ATCC, LGC) derived 
from mouse embryo fibroblasts and in primary neocortical neuron cultures obtained from E17 mouse embryos (CD1, 
Charles River). Culture medium was DMEM supplemented with 10% serum (calf serum for 3T3 and fetal bovine serum 
for neuron cultures) and 50 µg.ml-1 gentamicin. Both 3T3 and neuron cultures were seeded in 24-well plates, at the 
densities of 8 x 103 and 2 x 105 cell.cm-2, respectively. Fibroblast cells were used at the exponential growth phase after 1 
- 2 days in vitro, and neurons when reaching maturity at 6 - 7 days in vitro. We changed well media to fresh media 
containing Fe/MgO nanoparticles at concentrations up to 1 mM total-metal molar concentration (Fe0). We carried out the 
6experimental incubations at the cell culture conditions of 37 ºC and 5% CO2 atmosphere, for 3 days. Survival was 
measured in both cell culture types by a live/death stain assay (double staining with fluorescein diacetate/propidium 
iodide), as described elsewhere,28 or the trypan blue exclusion assay. No cytotoxic effects were detected either with 
fluorescein diacetate/propidium iodide (Fig. 4a and c) or with trypan blue staining. Additionally, 24h proliferation rate 
was determined in 3T3 by cell counting in a hemocytometer (Fig. 2b). Data show the average ± standard deviation of 
triplicate assays.
II.C.2. In vivo Toxicity: We maintained 5 female and 5 male CD1 mice (25 - 35 g) in accordance with the 
guidelines and under the approval of CEEA animal care committee of Universitat de Barcelona, Spain. Mice were 
injected through the vein tail with a solution (10 μl per animal gram) of Fe/MgO nanoparticles dispersed in PBS at the 
concentration of 1 mM Fe0. The mice did not show symptoms of discomfort after dosing. Animals were regularly 
monitored for three weeks, sacrificed and autopsied. No changes in body weight and behaviour or macroscopic 
alterations of internal organs were detected. 
II.D.1. Relaxivity measurements: T2 relaxation times were measured using an inversion-recovery pulse sequence 
with a Bruker Minispec (Bruker Analytics, North Bellirica, MA) at 37°C and 0.47 T (20 MHz).
II.D.2. MRI imaging and biodistribution: MRI was performed on a 7 Tesla Bruker BioSpec to obtain T2 maps 
using a MSME sequence with the following parameter: TE = 15.20 - 242.92 ms (16 echos), TR = 3573 ms, acquiring 13 
contiguous 1.5 mm slices with a 7.99 × 3.99 cm2 field of view (FOV), and acquisition matrix = 512 × 256 MRI T2-
weighted images of mice under ketamine anaesthesia were acquired at room temperature. Theoretical considerations
predict linear correlations between the proton transverse relaxation rate and concentration of magnetic ions [29]. Here 
the challenge was to develop a method that provides quantitative information. Therefore, for ex vivo magnetic particle 
quantization, the animals were sacrificed. The livers, spleen and kidneys were eviscerated, placed in individual tubs (~
0.15 cm3) and frozen for vibrating sample magnetometer analysis. Thanks to the strong ferromagnetic behaviour, NPs 
could be easily distinguished from the blood pool. Kidney and spleen magnetic signals were at least an order of 
magnitude lower than the signal measured from the liver, demonstrating primarily hepatic accumulation.
7III.RESULTS AND DISCUSSION
A general view of the obtained samples is shown in the electron microscopy image of Fig. 1, 
here displaying nearly spherical nanoparticles with a primary diameter of about 75 nm and 16% 
standard deviation, in good agreement with the log-normal distribution of particle size expected 
based on modelling results on the Brownian aggregation of atoms within the free molecular 
regime.30 High-resolution transmission electron microscopy (TEM) and dark-field imaging clearly 
showed a MgO layer overcoating a crystalline body-centered-cubic Fe core. Powder X-ray 
diffraction (XRD) patterns could be indexed to MgO and Fe crystalline phases (Fig. 1d) with no 
evidences for the presence of iron oxides, despite the broadening of the diffraction profile at low 
angles due to the presence of Mg(OH)2 during the passivation process in air. Due to the Mg-MgO 
excess in the initial batch composition, we also observed that a substantial fraction of the sample is 
in the form of MgO particles with cube morphology confined only by the 6{100} planes with the 
lowest surface energy (Fig. 1f). Therefore, the Fe-core nucleation and MgO-shell growth prove to be 
differentiated. Assuming that the MgO self-assemble on the Fe surface because of differences in 
surface energy, interfacial stress probably modifies the radial growth of the shell and limits the MgO 
thickness.31
Additional information about the nature of Fe/MgO interface was obtained by using 
Mössbauer spectroscopy (Fig. 2a). Results (Table 1) indicate the ferromagnetic character of the NPs. 
The observed intensity ratio 3:2:1 between the sextet lines and the value of the hyperfine magnetic 
field (Hi  330 kOe) indicates that the core of the particles is integrated by -Fe. On the other hand, 
the hyperfine parameters of the doublet, isomer shift (IS) and quadrupolar splitting (Δ), exhibit 
typical values of Fe3+ cations in octahedral coordination. 32 , 33 We suggest that, for charge 
compensation at the interface, the Fe3+ submonolayer formation involves Mg2+ vacancies originating 
from the Mg(OH)2 passivation.
34
8As expected, the resulting powders are strongly attracted to a permanent magnet (inset Fig.
2b), therefore can be employed to separate active nanoparticles in a reaction medium. Magnetization 
measurements (Fig. 2c) indicate that blocking temperature is well above 300 K. By determining the 
total Fe amount using energy dispersive X-ray analysis, we found the saturation magnetization (MS)
values (MS  217 e.m.u.g-1 at 10 K and MS  210 e.m.u.g-1 at 300 K) very close to that of pure bcc 
iron (bulk Fe  223 e.m.u.g-1). The inset in Fig. 2c shows a magnification of the low field regime 
making evident that samples have a coercivity (HC) of about 180 Oe at 300 K, close to the value 
calculated for magnetization reversal of spherical single domain Fe grains.35 Importantly, the very 
low remanence, compared to an assembly of randomly oriented non-interacting nanoparticles,36
explains the organization of chains of nanospheres by magnetic flux closure states.37
Interestingly, magnetostatic interactions of the particles moments may alter the frequency 
dependence of the hyperthermia response.18,37 We explored the potential use of the ferromagnetic 
properties of the Fe/MgO particles for cancer therapy by carrying out heating experiments. We 
found that under field amplitude H = 250 Oe and frequency f = 765 kHz nanoparticles solutions 
exhibited significant temperature increases over time (Fig. 3). A very high specific absorption rate 
(SAR) in the order of 450 W.g-1 (per Fe gram) was found (Fig. 3 b), close to the losses power 
estimated theoretically to be proportional to the square of the moment.18 Typically, ferrofluid 
samples investigated in literature show SAR values in the order of 100 W.g-1. This demonstrated 
Fe/MgO NPs as high performance therapy vectors capable of induce heat at lower doses than 
existing materials.
To test the efficacy of our nanomaterial as imaging agent for MRI, we measured longitudinal 
(T1) and transverse (T2) relaxation times of protons in water solutions in a 0.47 T magnetic field, 
derived r1 and r2 relaxivities and compared them (Table 2) with commercial MRI contrast agents and 
data from literature.15, 17, 38 A remarkable result was that Fe/MgO NPs, as a consequence of the large 
9magnetic nucleus, exhibited quite elevated r2 values (152 mM
-1.s-1) despite not being fully saturated.
Therefore, even higher effects on relaxation times are expected on clinical equipments. Also 
important was that our NPs revealed a very high r2/r1 ratio making them affording effective as T2
negative-contrast agents.39,40
In terms of biocompatibility, our in vitro toxicity assays on two different cell lines shown no 
deleterious biological properties (Fig. 4). These results were expected considering the antiseptic 
properties of MgO by virtue of its basicity.22 In preliminary in vivo animal experiments, we 
intravenously injected 10 μl.g-1 of saline solution at 1 mM Fe0 molar concentration into mice (total 
iron dose about 0.6 mg.kg-1), and observed no apparent acute toxicity or side-effects health problems 
over a monitoring period of 3 weeks, though of fear of raising the likelihood of blood vessel 
blockage due to particles-cluster formation by magnetic interaction. We suggest that hydrodynamic 
forces together with the gathering of NPs into elongated assemblies may improve the ability of the 
active cores to circulate.38
To address the biodistribution, animals were imaged using MRI (Fig. 5). We distinguished 
intensity changes in T2-weighted MR images before injection, as well as 1 day and three weeks after 
injection. The distribution of particles in the mouse 24 h post injection is similar to that reported 
previously for iron oxides particles with similar physical characteristics.41 This particles display a 
tendency to undergo phagocytic system clearance in the liver, spleen and kidneys. Significantly, the 
values measured for MRI are consistent with the magnetic data analysis of excised organs. A 
significant fraction of the iron was shown to enter the liver, as can be detected qualitatively in T2-
weighted images by the liver hypo-intensity at 24h and 21 days after contrast injection. Accordingly, 
T2 maps show decrease T2 values in the liver after contrast administration (T2 = 15.12 ms before 
injection, and equals 10.59 ms at 24h after injection).42
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IV.CONCLUSIONS
A remarkable result was that the hysteresis cycle taken from tissue several days after injection
resembled that of the NPs powder, demonstrating the particle in vivo solidity. Even in case the 
magnetic nanoparticles start to break down, any Fe and Mg amount will be diluted and regulated 
within the body. Given that a clinical dose would likely include a few milligrams of Fe per kilogram 
body mass, the prospect of iron overload is highly unlikely.43 This result achieved a major goal for 
MRI contrast-agent and hyperthermia development, from which haemosiderin deposits, and 
eventually organ disfunction, could be minimized. Although our studies may be considered as a first 
proof-of-principle approach, further work is still needed to investigate the biocompability of the 
nanocrystals in various in vivo applications.
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Figure Captions
Figure 1. Particle morphology and size distribution. a) General view of the Fe particles 
deposited on a carbon-film-covered TEM grid. b) Histogram of particles sizes. The curve 
corresponds to the log-normal probability distribution. c) Composition distribution across a 
Fe/MgO particle acquired by EDX. Inset shows the electron beam scan. d) Podwer-XRD pattern 
of as-prepared product, from a mixture of MgO, Mg and Fe. Peaks are assigned to face-centred-
cubic MgO and body-centred-cubic Fe. e) A high-resolution TEM image showing a core-shell 
structured nanoparticle. The inset exhibits the FFT spectrum taken from the boxed area of the 
image across the interface. Spots corresponding to the MgO viewed along the [111] zone axis 
(marked with circles) and the (110)Fe (indicated by squares) are shown. These results indicate a 
tendency towards aligning [011]Fe with [100]MgO, giving rise to a low mismatch orientation 
similar to the one found in thin films. f) Micrograph of a MgO cube in the vicinity of magnesia-
coated Fe sphere. 
Figure 2. Magnetic properties of the Fe/MgO nanocrystals. a) Mössbauer spectra 
registered at 80 K and room temperature. The solid lines are least-squares fits of the 
experimental points into the superposition of various iron phases. Spectra components in blue 
are associated with the interfacial Fe3+ sites. b) Field-cooled and zero-field-cooled magnetization 
measured with an applied magnetic field of 100 Oe. Inset shows the strong attraction of NPs in 
water suspension towards a magnet. c) High-field hysteresis loops for ~80 nm nanocrystals 
measured after several months exposure in ambient air. Inset: low field region at RT (circles) 
and 10 K (squares) after field-cooled experiment at 50 kOe. 
Table
Figure 3. a) Heating performance of particles aqueous suspensions under 250 Oe and 765 
kHz. b) Field-amplitude dependence of SAR at 21 mM (dots) and 10.5 mM (squares) 
concentration. Heavy line is the loss power determined from minor hysteresis loops.
Figure 4. In vitro biocompatibility analysis. a) Cytotoxicity test on mouse fibroblast 3T3 
cells, by incubation with Fe/MgO particles for 3 days. Cells were labeled with fluorescein 
diacetate (green, that reveals cytoplasmic esterase activity in living cells) and propidium iodide 
(read, dead cells with disrupted membrane) with no effects up to the maximum concentration 
tested of 1000 μM Fe0. Upper row, phase contrast; lower row, living/death stain; magnification: 
100×. b) Dose-dependent proliferation assay on 3T3 cells, by monitoring the 24 h cell growth. 
Normal proliferation rates were obtained at all concentrations tested. c) Cytotoxicity test on 
primary neuron cultures, by incubation with Fe/MgO particles for 3 days. Cells were labeled 
with fluorescein diacetate and propidium iodide, with no effects at the maximum concentration 
tested. Upper row, phase contrast; lower row, living/death stain; magnification: 200×.
Figure 5. a) T2-weigthed MR images of mouse body before (left) and after injection of 
nanoparticles. Due to the negative contrast properties of the solution, the liver appears hypo-
intense in images after contrast injection (see arrow). b). Colour-coded  T2 maps, from yellow 
(that is, high T2) to green (low T2). The large magnetic susceptibility of the nanoparticles distorts 
the local magnetic field in its vicinity, causing the nearby water protons to relax more rapidly, 
i.e. shortening T2 of tissues containing these particles. Thus, as expected, T2 maps show a 
decrease in T2 values in the liver after contrast administration. c) Comparison of magnetic signal 
from targeted liver at the same time points as imagined by MRI.
Table 1. Hyperfine parameters at 300 and 80 K for particles produced from an initial 
MgO60Mg15Fe25 (% wt.) target composition. Hi: hyperfine magnetic field, in Teslas; IS: isomer 
shift (all the shifts are referred to α-Fe at 298 K) in mm.s-1; Δ: quadrupole splitting in mm.s-1; 2ε: 
quadrupolar shift in mm.s-1; P: relative peak area of iron species. The accuracy of the values 
obtained from the statistics errors given by the fitting procedure is indicated in parentheses.
T (K) fit Hi Δ 2 IS P (%)
300
doublet - 0.93(8) - 0.47(5) 12
sextet 32.9(2) - -0.003(4) 0.003(2) 88
80
doublet - 0.92(9) - 0.538(8) 7
sextet 33.8(1) - -0.002(6) 0.118(4) 93
Table 2. Relaxativities r1, r2 and r2/r1 ratios for Fe/MgO nanoparticles compared to 
reported values in literature. The unusually r2/r1 higher than conventional Gd and iron-oxide 
based contrast agents may open new possibilities in negative-contrast MRI.
sample Applied field (T) r1 (mM
-1.s-1) r2 (mM
-1.s-1) r2/r1
80 nm Fe/MgO 0.47 1.15 152 132
7  nm FeCo [15] 1.5 70 644 9.2
Feridex® [15] 1.5 10 104 10.4
Magnevist® [15] 1.5 4.6 4.5 1
12 nm MnFe2O4 [17] 1.5 _ 358 _
5 nm FeOx chains [38] 4.7 _ 116 _
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